Xencor, Inc. (XNCR) stock analysis

In our weekly check, Xencor, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 4 pass, warnings: 1, red flags: 13.

Sector: Healthcare · Biotechnology

Warning signs

Next earnings report: 2026-11-04

Similar companies

SRPT · AGIO · ZBIO · PVLA · NUVB · LEGN

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.

Updated 2026-10-03

Open the full analysis